Efficacy and Safety of Sorafenib Therapy on Metastatic Renal Cell Carcinoma in Korean Patients: Results from a Retrospective Multicenter Study

• Sung Han Kim,

  Affiliation Departments of Urology, Center for Prostate Cancer, National Cancer Center, Goyang, Korea

  ⨯
• Sohee Kim,

  Affiliation Biometric Research Branch, Center for Prostate Cancer, National Cancer Center, Goyang, Korea

  ⨯
• Byung-Ho Nam,

  Affiliation Biometric Research Branch, Center for Prostate Cancer, National Cancer Center, Goyang, Korea

  ⨯
• Sang Eun Lee,

  Affiliation Seoul National University Bundang Hospital, SeongNam, Korea

  ⨯
• Choung Soo Kim,

  Affiliation Asan Medical Center, Seoul, Korea

  ⨯
• Ill Young Seo,

  Affiliation Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

  ⨯
• Tae Nam Kim,

  Affiliation Pusan National University Hospital, Busan, Korea

  ⨯
• Sung-Hoo Hong,

  Affiliation Seoul St. Mary’s Hospital, Seoul, Korea

  ⨯
• Tae Gyun Kwon,

  Affiliation School of Medicine, Kyungpook National University, Daegu, Korea

  ⨯
• Seong Il Seo,

  Affiliation Wonkwang University School of Medicine and Hospital, Iksan, Korea

  ⨯
• Kwan Joong Joo,

  Affiliation Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea

  ⨯
• Kanghyon Song,

  Affiliation Korea Cancer Center Hospital, Seoul, Korea

  ⨯
• Cheol Kwak,

  Affiliation Seoul National University Hospital, Seoul, Korea

  ⨯
• Jinsoo Chung

  * E-mail: cjs5225@ncc.re.kr

  Affiliation Departments of Urology, Center for Prostate Cancer, National Cancer Center, Goyang, Korea

  ⨯